Literature DB >> 23628482

Assessing quality in cross-country comparisons of health systems and policies: towards a set of generic quality criteria.

Mirella Cacace1, Stefanie Ettelt, Nicholas Mays, Ellen Nolte.   

Abstract

There is a growing body of cross-country comparisons in health systems and policy research. However, there is little consensus as to how to assess its quality. This is partly due to the fact that cross-country comparison constitutes a diverse inter-disciplinary field of study, with much variation in the motives for research, foci and levels of analyses, and methodological approaches. Inspired by the views of subject area experts and using the distinction between variable-based and case-based research, we briefly review the main different types of cross-country comparisons in health systems and policy research to identify pertinent quality issues. From this, we identify the following generic quality criteria for cross-country comparisons: (1) appropriate use of theory, (2) explicit selection of comparator countries, (3) rigour of the comparative design, (4) attention to the complexity of cross-national comparison, (5) rigour of the research methods, and (6) contribution to knowledge. This list may not be exclusive though publication and discussion of the list of criteria should help raise awareness in this field of what constitutes high quality research. In turn, this should be helpful for those planning, undertaking, or commissioning cross-country comparative research.
Copyright © 2013 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Keywords:  Case-oriented design; Comparative method; Cross-country comparisons; Health policy research; Health system research; International comparisons; Research quality criteria; Variable-oriented design

Mesh:

Year:  2013        PMID: 23628482     DOI: 10.1016/j.healthpol.2013.03.020

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  19 in total

1. 

Authors:  David Ponka; Luiz Felipe Pinto; Ophelia Michaelides; Katherine Rouleau
Journal:  Can Fam Physician       Date:  2018-11       Impact factor: 3.275

2.  Challenges facing efforts to strengthen primary health care: The Besrour Papers: a series on the state of family medicine in Canada and Brazil.

Authors:  David Ponka; Luiz Felipe Pinto; Ophelia Michaelides; Katherine Rouleau
Journal:  Can Fam Physician       Date:  2018-11       Impact factor: 3.275

Review 3.  The Cross-Country Comparison Model for Labor Participation (CCC Model for LP) of Persons with Chronic Diseases.

Authors:  Angelique de Rijk; Karina Carrasco-Negüe; Inge Houkes
Journal:  J Occup Rehabil       Date:  2022-06-20

4.  Self-Care and Mobility Following Postacute Rehabilitation for Older Adults With Hip Fracture: A Multilevel Analysis.

Authors:  Michael P Cary; Wei Pan; Richard Sloane; Janet Prvu Bettger; Helen Hoenig; Elizabeth I Merwin; Ruth A Anderson
Journal:  Arch Phys Med Rehabil       Date:  2016-02-01       Impact factor: 3.966

5.  Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications.

Authors:  Brian Godman; Max Petzold; Kathleen Bennett; Marion Bennie; Anna Bucsics; Alexander E Finlayson; Andrew Martin; Marie Persson; Jutta Piessnegger; Emanuel Raschi; Steven Simoens; Corinne Zara; Corrado Barbui
Journal:  BMC Med       Date:  2014-06-13       Impact factor: 8.775

6.  Different initiatives across Europe to enhance losartan utilization post generics: impact and implications.

Authors:  James C Moon; Brian Godman; Max Petzold; Samantha Alvarez-Madrazo; Kathleen Bennett; Iain Bishop; Anna Bucsics; Ulrik Hesse; Andrew Martin; Steven Simoens; Corinne Zara; Rickard E Malmström
Journal:  Front Pharmacol       Date:  2014-10-08       Impact factor: 5.810

7.  Policy implementation for methicillin-resistant Staphylococcus aureus in seven European countries: a comparative analysis from 1999 to 2015.

Authors:  Takuya Kinoshita; Hironobu Tokumasu; Shiro Tanaka; Axel Kramer; Koji Kawakami
Journal:  J Mark Access Health Policy       Date:  2017-07-26

8.  Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries.

Authors:  Tomasz Bochenek; Vafa Abilova; Ali Alkan; Bogdan Asanin; Iñigo de Miguel Beriain; Zeljka Besovic; Patricia Vella Bonanno; Anna Bucsics; Michal Davidescu; Elfi De Weerdt; Natasa Duborija-Kovacevic; Jurij Fürst; Mina Gaga; Elma Gailīte; Jolanta Gulbinovič; Emre U Gürpınar; Balázs Hankó; Vincent Hargaden; Tor A Hotvedt; Iris Hoxha; Isabelle Huys; Andras Inotai; Arianit Jakupi; Helena Jenzer; Roberta Joppi; Ott Laius; Marie-Camille Lenormand; Despina Makridaki; Admir Malaj; Kertu Margus; Vanda Marković-Peković; Nenad Miljković; João L de Miranda; Stanislav Primožič; Dragana Rajinac; David G Schwartz; Robin Šebesta; Steven Simoens; Juraj Slaby; Ljiljana Sović-Brkičić; Tomas Tesar; Leonidas Tzimis; Ewa Warmińska; Brian Godman
Journal:  Front Pharmacol       Date:  2018-01-18       Impact factor: 5.810

9.  The Besrour Papers: Seeking evidence for family medicine.

Authors:  David Ponka
Journal:  Afr J Prim Health Care Fam Med       Date:  2017-09-26

10.  Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future.

Authors:  Winnie de Bruijn; Cristina Ibáñez; Pia Frisk; Hanne Bak Pedersen; Ali Alkan; Patricia Vella Bonanno; Ljiljana S Brkičić; Anna Bucsics; Guillaume Dedet; Jaran Eriksen; Joseph O Fadare; Jurij Fürst; Gisselle Gallego; Isabella P Godói; Augusto A Guerra Júnior; Hakkı Gürsöz; Saira Jan; Jan Jones; Roberta Joppi; Saim Kerman; Ott Laius; Newman Madzikwa; Einar Magnússon; Mojca Maticic; Vanda Markovic-Pekovic; Amos Massele; Olayinka Ogunleye; Aisling O'Leary; Jutta Piessnegger; Catherine Sermet; Steven Simoens; Celda Tiroyakgosi; Ilse Truter; Magnus Thyberg; Kristina Tomekova; Magdalena Wladysiuk; Sotiris Vandoros; Elif H Vural; Corinne Zara; Brian Godman
Journal:  Front Pharmacol       Date:  2016-07-22       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.